Interdisciplinary Working Group for Movement Disorders
Botulinum toxin assessment, intervention and after-care for lower limb spasticity in children with cerebral palsy: international consensus statement: Love SC et al.
European Journal of Neurology 2010, 17 (Suppl. 2): 9–3
doi:10.1111/j.1468-1331.2010.03126.
doi:10.1111/j.1468-1331.2010.03126.
Authors
S. C. Love a,
S. C. Love a,
I. Novak b,
M. Kentish c,
K. Desloovere d.
F. Heinen e,
G. Molenaers f,
S. O. Flaherty g
and H. K. Graham h
Author Details
a Centre for Musculoskeletal Studies, University of Western Australia, Princess Margaret Hospital, Western Australia;
b Cerebral Palsy Institute, School of Medicine, University of Notre Dame Australia, Darlinghurst, Sydney, NSW;
c Queensland Cerebral Palsy Health Service, Department of Paediatric Rehabilitation, Royal Children’s Hospital, Brisbane, QLD, Australia;
d Department of Rehabilitation Sciences, KUL, Leuven, Belgium;
e Paediatric Neurology & Developmental Medicine, Children’s Hospital University of Munich, Munich, Germany;
f Department of Musculoskeletal Sciences, KUL, Leuven, Belgium;
g Rehabilitation Dept, Children’s Hospital at Westmead, Westmead, NSW, Australia; and
h University of Melbourne, Department of Orthopaedics and Murdoch Children’s Research Institute, The Royal Children’s Hospital, Parkville, Vic., Australia
Unsere Zertifizierer
